Let's break down Cipla Ltd. (CIPLA) — from its financial performance to how the market is valuing the stock.
Cipla Revenue Trend
Year-over-year, Cipla Ltd. grew revenue by 2.2% — from ₹28,409 Cr in FY2025 to ₹29,045 Cr in FY2026.
A 7.8% CAGR over 10 years is middle-of-the-road. Cipla Ltd.'s top line moved from ₹13,678 Cr to ₹29,045 Cr in that period.
A ₹29,045 Cr revenue base makes Cipla Ltd. a major name in the Indian pharmaceuticals sector.
Cipla Ltd. has posted revenue growth for 10 consecutive years — that's a sustained trend, not a one-off.
| Year | Revenue | YoY % |
|---|---|---|
| FY2026 | ₹29,045 Cr | +2.2% |
| FY2025 | ₹28,409 Cr | +7.1% |
| FY2024 | ₹26,521 Cr | +16.6% |
| FY2023 | ₹22,753 Cr | +4.5% |
| FY2022 | ₹21,763 Cr | — |
View Cipla Ltd.'s full 10-year revenue trend with CAGR analysis →
Cipla Profitability
Cipla Ltd.'s profitability took a step back in FY2026, with net income falling 26.7% to ₹3,862 Cr.
A drop in net margin from 18.5% to 13.3% in FY2026 suggests costs grew faster than revenue.
Diluted EPS came in at ₹48.00 for FY2026, down from ₹65.24 a year earlier.
Is Cipla Undervalued
Based on the P/E Ratio model, Cipla Ltd.'s fair value works out to ₹1,441 — 1.0% upside from where it trades today.
Cipla Ltd. shares are currently trading at ₹1,426.70.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹1,441 | 1.0% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Cipla Ltd. with detailed assumptions →
Cipla Shareholding Pattern
Promoter holding is steady at 29.2% — no buying or selling over the past 4 quarters.
Foreign investors held 22.6% of the company as of March 2026, down year-over-year from 25.2%.
Domestic institutions moved their stake up to 32.0% from 29.3% over the past year.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 29.2% | 22.6% | 32.0% | 16.2% |
| Dec 2025 | 29.2% | 23.9% | 30.7% | 16.1% |
| Sep 2025 | 29.2% | 24.6% | 30.2% | 16.0% |
| Jun 2025 | 29.2% | 25.2% | 29.3% | 16.3% |
Track quarterly shareholding changes for Cipla Ltd. →
Cipla Balance Sheet
Proportional view as of 13 Jul 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2026 total assets: ₹424.96B (up 13.7% YoY from ₹373.87B).
Top categories: Cash & ST Investments (20.5%), Property, Plant & Equipment (16.9%), Other Assets (16.5%).
Of the ₹424.96B in liabilities and equity, 81.2% is shareholder equity, 1.4% is interest-bearing debt, and 17.3% is operating liabilities. Over the year, debt is up 40.1% and equity is up 10.3%.
Balance sheet composition — FY 2026
| Category | Value |
|---|---|
| Cash & ST Investments | 86.98B |
| Receivables | 56.20B |
| Inventories | 65.97B |
| Property, Plant & Equipment | 71.73B |
| Investments | 5.44B |
| Intangibles & Goodwill | 68.51B |
| Other Assets | 70.14B |
| Category | Value |
|---|---|
| Equity | 345.20B |
| Short-term Debt | 2.32B |
| Long-term Debt | 3.82B |
| Trade Payables | 32.30B |
| Other Liabilities | 41.32B |
What Stands Out About Cipla
In summary, Cipla Ltd. (CIPLA) presents the following picture for fundamental analysts.
Revenue of ₹29,045 Cr in FY2026, up 2.2% year-over-year.
Long-term revenue has been compounding at 7.8% annually over 10 years.
The company is profitable, with a net margin of 13.3% and net income of ₹3,862 Cr.
The P/E Ratio model implies 1.0% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Cipla Ltd.'s detailed profile on Craytheon.